• While it is very small relative to big competitors, it is growing much faster than the market, leading to margin expansion and operational leverage.
• Introducing new tests, a new consumer business, doing testing for others and international growth are some of the multiple growth avenues in front of the company.
• The company seems to have a cost and speed advantage over bigger rivals.

Source: Fulgent Genetics’ Impressive Growth Acceleration Has Further To Run – Fulgent Genetics, Inc. (NASDAQ:FLGT) | Seeking Alpha